advertisement
Onoe H 20
Showing records 1 to 20 | Display all abstracts from Onoe H109726 Posterior sclerectomy for persistent serous retinal detachment with secondary glaucoma in Sturge-Weber syndrome: A case report
Nurtania A
Medicine 2023; 102: e34144
109276 Vision-Related Quality of Life following Combined Cataract and Minimally Invasive Glaucoma Surgery or Cataract Surgery Alone in Glaucoma Patients
Yuasa Y
Journal of clinical medicine 2023; 12:
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Mizuno Y
Contemporary clinical trials communications 2023; 33: 101160
109726 Posterior sclerectomy for persistent serous retinal detachment with secondary glaucoma in Sturge-Weber syndrome: A case report
Kiuchi Y
Medicine 2023; 102: e34144
109276 Vision-Related Quality of Life following Combined Cataract and Minimally Invasive Glaucoma Surgery or Cataract Surgery Alone in Glaucoma Patients
Hirooka K
Journal of clinical medicine 2023; 12:
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Komatsu K
Contemporary clinical trials communications 2023; 33: 101160
109276 Vision-Related Quality of Life following Combined Cataract and Minimally Invasive Glaucoma Surgery or Cataract Surgery Alone in Glaucoma Patients
Okada N
Journal of clinical medicine 2023; 12:
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Tokumo K
Contemporary clinical trials communications 2023; 33: 101160
109726 Posterior sclerectomy for persistent serous retinal detachment with secondary glaucoma in Sturge-Weber syndrome: A case report
Muhlisah A; Hirooka K
Medicine 2023; 102: e34144
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Okada N
Contemporary clinical trials communications 2023; 33: 101160
109276 Vision-Related Quality of Life following Combined Cataract and Minimally Invasive Glaucoma Surgery or Cataract Surgery Alone in Glaucoma Patients
Onoe H
Journal of clinical medicine 2023; 12:
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Onoe H
Contemporary clinical trials communications 2023; 33: 101160
109726 Posterior sclerectomy for persistent serous retinal detachment with secondary glaucoma in Sturge-Weber syndrome: A case report
Okada N
Medicine 2023; 102: e34144
109276 Vision-Related Quality of Life following Combined Cataract and Minimally Invasive Glaucoma Surgery or Cataract Surgery Alone in Glaucoma Patients
Murakami Y; Okumichi H
Journal of clinical medicine 2023; 12:
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Okumichi H
Contemporary clinical trials communications 2023; 33: 101160
109726 Posterior sclerectomy for persistent serous retinal detachment with secondary glaucoma in Sturge-Weber syndrome: A case report
Onoe H
Medicine 2023; 102: e34144
109276 Vision-Related Quality of Life following Combined Cataract and Minimally Invasive Glaucoma Surgery or Cataract Surgery Alone in Glaucoma Patients
Kiuchi Y
Journal of clinical medicine 2023; 12:
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Hirooka K
Contemporary clinical trials communications 2023; 33: 101160
109726 Posterior sclerectomy for persistent serous retinal detachment with secondary glaucoma in Sturge-Weber syndrome: A case report
Tokumo K
Medicine 2023; 102: e34144
109619 A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
Miura Y; Kiuchi Y
Contemporary clinical trials communications 2023; 33: 101160
